Alpelisib (BYL719)
|
|
- CAS-Nr.
- 1217486-61-7
- Englisch Name:
- Alpelisib (BYL719)
- Synonyma:
- Alpelisib;Piqray;BYL-719;CS-614;100803;BLV-719;BYL-719 /BYL719;Alpelisib (BYL719);BYL-719(Alpelisib);Alpelisib (BLY-719
- CBNumber:
- CB52604234
- Summenformel:
- C19H22F3N5O2S
- Molgewicht:
- 441.47
- MOL-Datei:
- 1217486-61-7.mol
|
Alpelisib (BYL719) Eigenschaften
- Dichte
- 1.391
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥22.07 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
- Aggregatzustand
- White solid.
- pka
- 6.29±0.70(Predicted)
- Farbe
- Off-white to light yellow
- InChIKey
- STUWGJZDJHPWGZ-LBPRGKRZSA-N
- SMILES
- N1(C(NC2=NC(C)=C(C3C=CN=C(C(C)(C)C(F)(F)F)C=3)S2)=O)CCC[C@H]1C(N)=O
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H373 |
Kann die Organe sch?digen bei l?ngerer oder wiederholter Exposition. |
Spezifische Zielorgan-Toxizit?t (wiederholte Exposition) |
Kategorie 2 |
Warnung |
|
P260, P314, P501 |
|
Sicherheit |
P260 |
Dampf/Aerosol/Nebel nicht einatmen. |
P314 |
Bei Unwohlsein ?rztlichen Rat einholen / ?rztliche Hilfe hinzuziehen. |
P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Alpelisib (BYL719) Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
BYL719 is an inhibitor of phosphoinositide 3-kinase α (PI3Kα; IC
50s = 4.6, 4, and 4.8 nM for wild-type, E545K mutant, and H1047R mutant PI3K, respectively). It is selective for PI3Kα over PI3Kβ, PI3Kδ, PI3Kγ, and PI4Kβ (IC
50s = 1,156, 290, 250, and 581 nM, respectively), as well as VPS34, mTOR, DNA-PK, and ATR (IC
50s = >9,100 nM for all). BYL719 (12.5, 25, and 50 mg/kg) reduces tumor volume in a PI3Kα-dependent Rat1-myr-p110α mouse xenograft model. It also reduces tumor burden in THP-1 acute myeloid leukemia (AML) and MCF-7 breast cancer mouse xenograft models. Formulations containing BYL719 have been used in the treatment of advanced or metastatic breast cancer.
Trademarks
Piqray
Alpelisib (BYL719) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Acetamide,N-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-
4-Methyl-2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridine
4-broMo-2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridine
4-methyl-2-(2,2,2-trifluoro-1-methyl-1-trimethylsilanyloxy-ethyl)pyridine
1,1,1-trifluoro-2-(4-methylpyridin-2-yl)propan-2-ol
1,1,1-trifluoro-2-(4-methylpyridin-2-yl)propan-2-yl methanesulfonate
N-(4-Methyl-5-(2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)-1H-iMidazole-1-carboxaMide
phenyl 4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-ylcarbamate
(S)-Pyrrolidin-2-carboxamid
1-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)propan-2-one
2-Acetyl-4-methylpyridine
2,4-Dimethylpyridin
Downstream Produkte
Alpelisib (BYL719) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 223)Lieferanten
1217486-61-7()Verwandte Suche:
- (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
- BYL-719 /BYL719
- BLV-719
- (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxaMide
- 1,2-Pyrrolidinedicarboxamide, N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-, (2S)-
- Alpelisib (BYL719)
- (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide BYL-719
- BYL-719
(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
- BYL-719(Alpelisib)
- (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)-pyridin-4-yl)thiazol-2-yl)pyrrolid
- ALPELISIB;BYL-719; BYL 719
- CS-614
- Alpelisib - NVP-BYL719 | BYL-719
- 100803
- (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
- Alpelisib, 98%, a potent and selective PI3Kα inhibitor
- (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide ISO 9001:2015 REACH
- Alpelisib (BLY-719
- (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine
- BYL-719
- Alpelisib
- Piqray
- Inhibitor,Phosphoinositide 3-kinase,PI3K,Alpelisib,inhibit,phosphorylation,p110α,cancer,BYL 719,antineoplastic,AKT,metastasis,mutant,BYL719,PIK3CA,breast
- (2S) - N1- [4-methyl-5- [2- (2,2,2-trifluoro-1,1-dimethylethyl) -4-pyridyl] -2-thiazolyl] -1,2-pyrrolidine dicarboxylamide
- Biopterin Impurity 2
- 1217486-61-7
- C19H22F3N5O2S
- Inhibitors
- Akt
- mTOR
- PI3K
- PI3K/Akt/mTOR
- Api
- API